INmune Bio receives $4.6M in R&D rebates from UK and Australia

Go back to INmune Bio receives $4.6M in R&D rebates from UK and Australia
(NASDAQ: INMB) Delayed: 2.22 -0.07 (3.06%)
Previous Close $2.29    52 Week High
Open $2.31    52 Week Low
Day High $2.36    P/E N/A 
Day Low $2.21    EPS
Volume 308,695